CGMAB Trademark

Trademark Overview


On Friday, March 2, 2018, a trademark application was filed for CGMAB with the United States Patent and Trademark Office. The USPTO has given the CGMAB trademark a serial number of 87818647. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 28, 2019. This trademark is owned by Phanes Therapeutics, Inc.. The CGMAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related ...
cgmab

General Information


Serial Number87818647
Word MarkCGMAB
Filing DateFriday, March 2, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 28, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 31, 2018

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Biological preparations for the treatment of cancer; Biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Ferments for pharmaceutical purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Medical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Tumor suppressing agents; Clinical medical reagents; Anti-diabetic pharmaceuticals; Anti-cancer preparations; Cellular function activating agents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhanes Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NamePhanes Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Trademark Events


Event DateEvent Description
Monday, October 28, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 28, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2019EXTENSION 1 GRANTED
Monday, March 11, 2019EXTENSION 1 FILED
Monday, March 11, 2019TEAS EXTENSION RECEIVED
Tuesday, September 25, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 31, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 31, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 25, 2018ASSIGNED TO LIE
Thursday, June 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 14, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, June 14, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 14, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, June 14, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, June 14, 2018ASSIGNED TO EXAMINER
Friday, March 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 6, 2018NEW APPLICATION ENTERED IN TRAM